Clinical trial
A Randomized, Placebo-controlled, Tourette Syndrome Study.
NCT00206323 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00206323 |
|---|---|
| Title | A Randomized, Placebo-controlled, Tourette Syndrome Study. |
| Official title | A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine the Safety and Efficacy of Topiramate in the Treatment of Tourette Syndrome (CAPSS-176) |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Ortho-McNeil Janssen Scientific Affairs, LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tourette Syndrome |
| Intervention type | Drug |
| Interventions | Topiramate (drug), placebo/sugar pill |
| Enrollment | 29 |
| Start date | Sep 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 12, 2020 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: